Daniel Montville, MD
Psychiatry · Rochester, MNNPI 1952806093
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (45.5%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Axsome Therapeutics, Inc. accounts for 89.4% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2024 at $15,052 and has fallen 69.1% since, to $4,644 in 2025. Among psychiatry clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 38 payments — averaging $520.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axsome Therapeutics, Inc.$18K
- Neuronetics, Inc.$2K
- Livanova USA, Inc.$134
- Tris Pharma Inc$42
- Tempus AI, Inc$29
- Sage Therapeutics, LLC$20
- plus $69 from 4 others
What the payments were for
- Consulting fees$9,00046%
- Speaking & faculty fees$7,67539%
- Travel & lodging$1,4637%
- Food & beverage$1,6228%
- Education$150%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axsome Therapeutics, Inc. | 20 | $17,680 |
| Neuronetics, Inc. | 8 | $1,802 |
| Livanova USA, Inc. | 1 | $134 |
| Tris Pharma Inc | 3 | $42 |
| Tempus AI, Inc | 1 | $29 |
| Sage Therapeutics, LLC | 1 | $20 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $20 |
| Lundbeck LLC | 1 | $19 |
| Almatica Pharma LLC | 1 | $16 |
| Alkermes, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$19,775 in reported general payments places this provider in the 95th percentile of 552 psychiatry providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 18 | $3,622 |
| Clozapine | 14 | $1,341 |
| Aripiprazole | 16 | $694 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 12 | $639 |
| Buprenorphine Hcl | 11 | $563 |
| Lamotrigine | 13 | $549 |
| Risperidone | 28 | $380 |
| Gabapentin | 20 | $374 |
| Bupropion XlBupropion Hcl | 27 | $340 |
| Methylphenidate Hcl | 13 | $325 |
| Atomoxetine Hcl | 14 | $308 |
| Hydroxyzine Hcl | 16 | $232 |
| Quetiapine Fumarate | 16 | $221 |
| Clonazepam | 17 | $184 |
| Trazodone Hcl | 25 | $164 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Rochester
- Mark FryeRochester$8K
- Peter JensenRochester$4K
- Paul CroarkinRochester$820
- Michael WardenRochester$557
- Gary ChaikinRochester$508
- Simon KungRochester$504
- Sujit VarmaEdina$581K
- Michael FarnsworthMankato$548K
- Danielle Magness-WellmannMankato$232K
- Craig VineSt Paul$136K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.